| Primary information |
|---|
| sequence ID | Seq_8352 |
| Peptide sequence | TLEIPGNSDPNFIPDGDFNSYVR |
| CancerPDF_ID | CancerPDF_ID44, |
| PMID | 16896061 |
| Protein Name | Complement C4 precursor |
| UniprotKB Entry Name | "CO4A_HUMAN,CO4B_HUMAN" |
| Fluid | Serum |
| M/Z | 856.33 |
| Charge | 1 |
| Mass (in Da) | 2566.2 |
| Profiling Technique | MALDI-TOF |
| Peptide Identification technique | Q/TOF MS/MS |
| Labelled/Label Free | Label Free |
| CancerPDF_ID | CancerPDF_ID44, |
| p-Value | 1.00E-05 |
| Software | MASCOT |
| Length | 23 |
| Cancer Type | Metastatic thyroid carcinomas |
| Database | NCBI refseq Protein Database |
| Modification | NA |
| Number of Patients | 40 metastatic thyroid carcinoma patients and 40 normal for training phase and 10 metastatic thyroid carcinoma and 10 normal individuals for independent validation |
| Regulation | NA |
| Validation | Independent validation |
| Sensitivity | 95% on independent dataset |
| Specificity | 95% on independent dataset |
| Accuracy | NA |
| Peptide Atlas | NA |
| IEDB | NA |